Obesity [obesidade]

dc.creatorGeloneze B.
dc.creatorErmetice M.N.
dc.creatorGeloneze S.R.
dc.date2007
dc.date2015-06-30T18:40:52Z
dc.date2015-11-26T14:31:21Z
dc.date2015-06-30T18:40:52Z
dc.date2015-11-26T14:31:21Z
dc.date.accessioned2018-03-28T21:34:42Z
dc.date.available2018-03-28T21:34:42Z
dc.identifier
dc.identifierRevista Brasileira De Medicina. , v. 64, n. SPEC. ISS., p. 41 - 49, 2007.
dc.identifier347264
dc.identifier
dc.identifierhttp://www.scopus.com/inward/record.url?eid=2-s2.0-38949193247&partnerID=40&md5=ff284f6220dec66bda6afed4ace97a67
dc.identifierhttp://www.repositorio.unicamp.br/handle/REPOSIP/104317
dc.identifierhttp://repositorio.unicamp.br/jspui/handle/REPOSIP/104317
dc.identifier2-s2.0-38949193247
dc.identifier.urihttp://repositorioslatinoamericanos.uchile.cl/handle/2250/1247347
dc.descriptionObesity is an epidemic disease in many countries, including Brazil. It is a multifactor disease, which depends on the interaction between genetic, behavioral and socio-cultural factors. It is important to recognize patients on risk of developing obesity and its co-morbidities in order to define objectives and improve treatment choices. The ideal weight concept must be changed to healthy weight concept. A 5 to 10% sustained weight loss has a positive effect on obese patient's health, even if the final proposed weight was not reached. The best approach is the combination of dietetic counseling and behavior changes (including physical activity) and anti-obesity medication in selected cases. No pharmacologic treatment must be used isolated. The conventional clinical treatment frequently fails in morbidly obese patients. Bariatric surgery is a safe option on these particular cases. However, the candidate to the bariatric surgery must be followed up by a multidisciplinary assistance group, even before surgery. Treatment success depends mainly on patient motivation. As obesity is a chronic disorder, treatment should be planned on a long term basis, according to the necessity of not only lose weight but also of the maintenance of this lost weight to really prevent co-morbidities. © Copyright Moreira Jr. Editora. Todos os direitos reservados.
dc.description64
dc.descriptionSPEC. ISS.
dc.description41
dc.description49
dc.descriptionWorld Health Organization. Obesity: Preventing and Managing the Global Epidemic. Report of a World Health Organization Consultation. Geneva: World Health Organization. 2000
dc.description256. WHO Obesity Technical Report Series, no 894Diretrizes brasileiras de Obesidade, Associação Brasileira para o Estudo da Obesidade e da Síndrome Metabólica, 2007I Diretriz Brasileira de Diagnóstico e Tratamento da Síndrome metabólica. Rev Soc Brás Hipert 2004
dc.description17(04)Calle EE, Thun MJ, Petrelli JM, Rodriguez C, Health CW Jr. Body-mass index and mortality in a prospective cohort of U.S. adults. N Engl J Med 1999
dc.description341:1097-105Zamboni, M., Armellini, F., Milani, M.P., Evaluation of regional body fat distribution: Comparison between W/H ratio and computed tomography in obeses women (1992) J Intern Med, 232 (4), pp. 341-347
dc.descriptionGeloneze, B., Repetto, E.M., Geloneze, S.R., Picolo, M., Cruzes, G., Tambascia, M.A., Hypertriglyceridemic waist: A useful tool to assess insulin resistances clinical practice (2002) Diabetes, 51 (SUPPL. 2), pp. A531
dc.descriptionAronne, L.J., Obesity as a disease: Etiology, treatment, and management considerations for the obese patient (2002) Obes Res, 10 (SUPPL. 2), pp. 95S-96S
dc.descriptionPi-Sunyer, F.X., A review of long-term studies evaluating efficacy of weight loss in ameliorating disorders associated with obesity (1996) Clin Ther, 18, pp. 1006-1035
dc.descriptionMasheb, R.M., Grilo, C.M., Weight loss expectations in patients with binge-eating disorder (2002) Obes Res, 10, pp. 309-314
dc.descriptionCowburn, G., Hillsdon, M., Hankey, C.R., Obesity management by life-style strategies (1997) Br Med Bull, 53, pp. 389-408
dc.descriptionGlenny, A.M., O'Meara, S., Melville, A., Sheldon, T.A., Wilson, C., The treatment and prevention of obesity: A systematic review of literature (1997) Int J Obes, 21, pp. 715-737
dc.descriptionPoston, W.S., Foreyt, J.P., Successful management of the obese patient (2000) Am Fam Physician, 61, pp. 3615-3622
dc.descriptionWadden, T.A., Foster, G.D., Behavioral treatment of obesity (2000) Med Clin North Am, 84, pp. 441-461
dc.descriptionGarrow, J.S., Summerbell, C.D., Meta-analysis: Effect of exercise, with or without dieting, on the body composition of overweight subjects (1995) Eur J Clin Nutr, 49, pp. 1-10
dc.descriptionMiller, W.C., Koceja, D.M., Hamilton, E.J., A meta-analysis of the past 25 years of weight loss research using diet, exercise, or diet plus exercise intervention (1997) Int J Obes, 21, pp. 941-947
dc.descriptionPoston, W.S.C., Haddock, C.K., Dill, P.L., Thayer, B., Foreyt, J.P., Lifestyle treatments in randomized clinical trials of pharmacotherapies for obesity (2001) Obes Res, 9, pp. 552-563
dc.descriptionAyyad, C., Andersen, T., Long-term efficacy of dietary treatment of obesity: A systematic review of studies published between 1931 and 1999 (2000) Obes Rev, 1 (2), pp. 113-119
dc.descriptionRivlin, R.S., Therapy of obesity with hormones (1975) N Engl J Med, 292, pp. 26-29
dc.descriptionBashin, S., Wallace, W., Lawrence, J.B., Lesch, M., Sudden death associated with thyroid hormone abuse (1981) Am J Med, 71, pp. 887-890
dc.descriptionSmith, H.J., Roche, A.H.G., Jagusch, M.F., Herdson, P.B., Cardiomyopathy associated with amphetamine administration (1976) Am Heart J, 91, pp. 792-797
dc.descriptionWeintraub, M., Long-term weight control study: Conclusions (1992) Clin Pharmacol Ther, 51, pp. 642-646
dc.descriptionAbenhaim, L., Moride, Y., Brenot, F., Appetite-suppressant drugs and the risk of primary pulmonary hypertension (1996) N Eng J Med, 335, pp. 609-616
dc.descriptionMark, E.J., Patalas, E.D., Chang, H.T., Evans, R.J., Kessler, S.C., Fatal pulmonary hypertension associated with short-term use of fenfluramine and phentermine (1997) N Eng J Med, 337, pp. 602-606
dc.descriptionConnoly, H.M., Xrary, J.L., McGoon, M.D., Hensrud, D.D., Edwards, B.S., Edwards, W.D., Schaff, H.V., Valvular heart disease associated with fenfluramine-phentermine (1997) N Eng J Med, 337, pp. 581-588
dc.descriptionWeissman, N.J., Tighe Jr, J.F., Gottdiener, J.S., Gwynne, J.T., An assessment of heart-valve abnormalities in obese in obese patients taking dexfenfluramine, sustained-release dexfenfluramine, or placebo N Eng J Med, 339, pp. 713-718
dc.descriptionWeissman, N.J., Panza, J.A., Tighe Jr, J.F., Gwynne, J.T., Natural history of valvular regurgitation 1 year after discontinuation of dexfenfluramine therapy. A randomized, double blind, controlled trial (2001) Ann Intern Med, 134, pp. 267-273
dc.descriptionKerman, W.N., Viscidly, C.M., Brass, L.M., Phenylpropanolamine and the risk of hemorrhagic stroke (2000) N Eng J Med, 343, pp. 1826-1832
dc.descriptionWeigle, D.S., Pharmacological therapy of obesity: Past, present, and the future (2003) J Clin Endocrinol Metab, 88, pp. 2462-2469
dc.descriptionSchuh, L.M., Schuster, C.R., Hopper, J.A., Mendel, C.M., Abuse liability assessment of sibutramine, a novel weight control agent (2000) Psychopharmacology, 147, pp. 339-346
dc.descriptionJames, W.P.T., Astrup, A., Finer, N., Hilsted, J., Kopelman, P., Rossner, S., Saris, W.H.M., Van Gaal, L.F., Effect of sibutramine on weight maintenance after weight loss: A randomized trial (2000) Lancet, 356, pp. 2119-2125
dc.descriptionHazenberg, B.P., Randomized, double-blind, placebo-controlled, multicenter study of sibutramine in obese hypertensive patients (2000) Cardiology, 94, pp. 152-158
dc.descriptionTambascia, M.A., Geloneze, B., Repetto, E.M., Geloneze, S.R., Picolo, M., Magro, D.O., Sibutramine enhances insulin sensitivity ameliorating metabolic parameters in a double blind placebo controlled trial (2003) Diab Obes Metab, , in press
dc.descriptionGuerciolini, R., Radu-Rdulescu, L., Boldrin, M., Dallas, J., Moore, R., Comparative evaluation of fecal fat excretion induced by orlistat and chitosan (2001) Obes Res, 9, pp. 364-367
dc.descriptionRossner, S., Sjostrom, L., Noack, R., Meinders, E., Noseda, G., Weight loss, weight maintenance, and improved cardiovascular risk factors after 2 years treatment with orlistat for obesity (2000) Obes Res, 8, pp. 49-61
dc.descriptionFiner, N., James, W.P.T., Kopelman, P.G., Lean, M.E.J., Willians, G., One-year treatment of obesity: A randomized, double-blind, placebo-controlled, multicentre study of orlistat, a gastrointestinal lipase inhibitor (2000) Int J Obes, 24, pp. 306-313
dc.descriptionLindgarde, F., The effect of orlistat on body weight and coronary heart disease risk profile in obese patients: The Swedish Multimorbidity Study (2000) J Intern Med, 248, pp. 245-254
dc.descriptionKarhunen, L., Franssila-Kallunki, A., Rissanen, P., Valve, R., Klehmainen, M., Rissanen, A., Uusitupa, M., Effect of orlistat treatment on body composition and resting energy expenditure during a two-year weight-reduction program in obese Finns (2000) Int J Obes, 24, pp. 1567-1572
dc.descriptionHill, J.O., Hauptman, J., Anderson, J.W., Orlistat, a lipase inhibitor, for weight maintenance after conventional dieting: A 1-year study (1999) Am J Clin Nutr, 69, pp. 1108-1116
dc.descriptionHeymesfield, S.G., Segal, K.R., Hauptman, J., Effects of weight loss with orlistat on glucose tolerance and progression to type 2 diabetes in obese adults (2000) Arch Intern Med, 160, pp. 1321-1326
dc.descriptionHalpern, A., Mancini, M.C., Suplicy, H., Zanella, M.T., Repetto, G., Gross, J., Jadzinsky, M., Matos, A.G., Latin-American trial of orlistat for weight loss and improvement in glycaemic profile in obese diabetic patients (2003) Diab Obes Metab, 5, pp. 180-188
dc.descriptionWadden, T.A., Berkowitz, R.I., Womble, L.G., Sarwer, D.B., Arnold, M.E., Steinberg, C.M., Effects of sibutramine plus orlistat in obese women following 1 year of treatment by sibutramine alone: A placebo-controlled trial (2000) Obes Res, 8, pp. 431-437
dc.descriptionVan Gaal, L.F., Rissanen, A., Scheen, A.J., Ziegler, O., Rössner, S., Effects of the cannabinoid-1 receptor blocker rimonabant on weight reduction and cardiovascular risk factors in overweight patients: 1-year experience from the RIO-Europe study (2005) Lancet, 365, pp. 1389-1397. , for the RioEurope Study Group
dc.descriptionPi-Sunyer, F.X., Aronne, L.J., Heshmati, H.M., Devin, J., Rosenstock, J., Effect of Rimonabant, a Cannabinoid-1 Receptor Blocker, on Weight and Cardiometabolic Risk Factorsin Overweight or Obese Patients. RIO-North America: A Randomized Controlled Trial (2006) JAMA, 295, pp. 761-775
dc.descriptionDesprés, J.P., Golay, A., Sjöström, L., Effects of Rimonabant on metabolic risk factors in overweight patients with dyslipidemia (2005) N Engl J Med, 353, pp. 2121-2134. , for the Rimonabant in Obesity-Lipids Study group
dc.descriptionScheen AJ, Finer N, Hollander P, Jensen MD, Van Gaal LF
dc.descriptionRIO-Diabetes Study Group. Efficacy and tolerability of rimonabant in overweight or obese patients with type 2 diabetes: a randomised controlled study. Lancet 2006
dc.description11:368:1660-72. Erratum in: Lancet 2006.11;368:1650Allison, D.B., Mentore, J.L., Heo, M., Antipsychotic-induced weight gain: A comprehensive research synthesis (1999) Am J Psychiatry, 156, pp. 1686-1696
dc.descriptionMasand, P.S., Weight gain associated with psychotropic drugs (2000) Exp Opin Pharmacother, 1, pp. 377-389
dc.descriptionMichelson, D., Amsterdam, J.D., Quitkin, F.M., Reimherr, F.W., Rosenbaum, J.F., Zajecka, J., Sundell, K.L., Beasley Jr., C.M., Changes in weight during a 1-year trial of fluoxetine (1999) Am J Psychiatry, 156, pp. 1170-1176
dc.descriptionGadde, K.M., Parker, C.B., Maner, L.G., Wagner II, H.R., Logue, E.J., Drezner, M.K., Krishnan, R.R., Bupropion for weight loss: An investigation of efficacy and tolerability in overweight and obese women (2001) Obes Res, 9, pp. 544-551
dc.descriptionBray, G.A., Hollander, P., Klein, S., Kushner, R., Levy, B., Fitchet, M., Perry, B.H., A 6-month randomized, placebo-controlled, dose ranging trial of topiramate for weight loss in obesity (2003) Obes Res, 11, pp. 722-733
dc.descriptionKorner, J., Lo, J., Freda, P.U., Wardlaw, S.L., Treatment with cabergoline is associated with weight loss in patients with hyperprolactinemia (2003) Obes Res, 11, pp. 311-312
dc.descriptionCincotta, A.H., Meier, A.H., Bromocriptine (Ergoset) reduces body weight and improves glucose tolerance in obese subjects (1996) Diabetes Care, 19, pp. 667-670
dc.descriptionNam, S.Y., Kim, K.R., Cha, B.S., Song, Y.D., Lim, S.K., Lee, H.C., Huh, K.B., Low-dose growth hormone treatment combined with restriction decreases insulin resistance by reducing fat and increasing muscle mass in obese type 2 diabetic patients (2001) Int J Obes, 25, pp. 1101-1107
dc.descriptionToubro, S., Astrup, A., Breum, L., Quaade, F., Safety and efficacy of long-term treatment with ephedrine, caffeine and an ephedrine/caffeine mixture (1993) Int J Obes, 17 (SUPPL. 1), pp. S73-S78
dc.descriptionBrolin, R.E., (1996) Update: NIH consensus conference. Gastrointestinal surgery for severe obesity. Nutrition, 12, pp. 403-404
dc.descriptionCapella, R.F., Capella, J.F., Vertical banded gastroplasty-gastric bypass: Preliminary report (1991) Obes Surg, 1, pp. 389-393
dc.descriptionScopinaro, N., Ginaetta, E., Adami, G.F., Biliopancreatic diversion for obesity at eighteen years (1996) Surgery, 119, pp. 261-268
dc.descriptionEvans, J.D., Scott, M.H., Intragastric balloon in the treatment of patients with morbid obesity (2001) Br J Surg, 88, pp. 1245-1248
dc.descriptionCigaina, V., Gastric pacing as therapy for morbid obesity: Preliminary results (2002) Obes Surg, 12 (SUPPL. 1), pp. 12S-16S
dc.descriptionChanoine JP, Hampl S, Jensen C, Boldrin M, Hauptman J. Effect of orlistat on weight and body composition in obese adolescents: a randomized controlled trial. JAMA 2005 15
dc.description293(23):2873-83Godoy-Matos A et al. Treatment of obese adolescents with sibutramine: A Randomized, double, Controlled Study. The Journal of Clinical Endocrinology and Metabolism2005
dc.description90(3):1460-1465Xanthakos, A.S., Daniels, S.R., Inge, T.H., Bariatric Surgery in adolescents: An update (2006) Adolesc Med Clin, 17 (3), pp. 589-612
dc.descriptionInge, T.H., Krebs, N.F., Garcia, V.F., Skelton, J.A., Guice, K.S., Strauss, R.S., Bariatric Surgery for severily overweight adolescents: Concerns and recommendations (2004) Pediatrics, 114 (1), pp. 217-223. , Review
dc.languagept
dc.publisher
dc.relationRevista Brasileira de Medicina
dc.rightsfechado
dc.sourceScopus
dc.titleObesity [obesidade]
dc.typeArtículos de revistas


Este ítem pertenece a la siguiente institución